1. Academic Validation
  2. Isolation and characterization of ARA160 as the first androgen receptor N-terminal-associated coactivator in human prostate cells

Isolation and characterization of ARA160 as the first androgen receptor N-terminal-associated coactivator in human prostate cells

  • J Biol Chem. 1999 Aug 6;274(32):22373-9. doi: 10.1074/jbc.274.32.22373.
P W Hsiao 1 C Chang
Affiliations

Affiliation

  • 1 Departments of Pathology, Urology, and Radiation Oncology, George Whipple Laboratory for Cancer Research, University of Rochester, Rochester, New York 14642, USA.
Abstract

The Androgen Receptor (AR) is a member of the steroid receptor superfamily that may require coactivators for proper or maximal transactivation. Using a purified AR N-terminal peptide as a probe to screen the human testis expression library, we identified an androgen-enhanced AR N-terminal-associated protein ARA160, which consists of 1,093 Amino acids with an apparent molecular mass of 160 kDa. Sequence comparison in GenBank(TM) reveals that ARA160 shares an identical sequence with a HIV-1 TATA element modulatory factor, TMF. The far-Western blotting and co-immunoprecipitation assays demonstrate that the AR can interact directly with ARA160/TMF. Affinity gel pull-down and mammalian two-hybrid assays further suggest androgen can enhance significantly the interaction between AR and ARA160. Transient transfection assays demonstrated that ARA160 might function as a coactivator for AR-mediated transactivation in human prostate Cancer PC-3 cells. Our data further suggest that this AR N-terminal coactivator can function cooperatively with AR C-terminal coactivator, ARA70, in PC-3 cells. Together, our data demonstrate that ARA160 might represent the first identified androgen-enhanced N-terminal coactivator for the AR.

Figures